Technical Analysis for CSBR - Champions Oncology, Inc.

Grade Last Price % Change Price Change
grade D 6.18 3.34% 0.20
CSBR closed up 3.34 percent on Friday, August 16, 2019, on 56 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Up
See historical CSBR trend table...

Date Alert Name Type % Chg
Wide Bands Range Expansion 0.00%
Slingshot Bearish Bearish Swing Setup 3.34%
Bullish Engulfing Bullish 3.34%
MACD Bullish Signal Line Cross Bullish 3.34%
Wide Bands Range Expansion 3.34%
New 52 Week Closing Low Bearish 10.75%
Stochastic Buy Signal Bullish 10.75%
Doji - Bullish? Reversal 10.75%
New 52 Week Low Weakness 10.75%
Wide Bands Range Expansion 10.75%

Older signals for CSBR ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Technology Platform, provides Personalized Oncology Solutions (POS) that assists physicians in developing personalized treatment options for cancer patients through tumor specific data obtained from drug panels and related personalized oncology services. It also offers POS products, including personalized tumor boards that are designed to provide access to oncologists with expertise in particular tumor types; and gene sequencing that analyzes the genetic makeup of patient's tumor for the purpose of identifying useful drugs. In addition, the company offers Translational Oncology Solutions (TOS), including a preclinical Tumorgraft platform to pharmaceutical and biotechnology companies that uses vivo studies, which rely on implanting multiple tumors from TumorBank in mice and testing the therapy of interest on tumors. Further, it provides a bank of tumors that are acquired, collected, processed, validated, and stored for the use in TOS. The company markets its products through Internet, word of mouth, and a network of sales force. It serves patients, physicians, and drug development companies. The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011 to reflect its new focus on developing technologies to personalize the development and use of oncology drugs. Champions Oncology, Inc. is headquartered in Hackensack, New Jersey.
Bank Health Biotechnology Cancer Technology Solutions Tumor Drug Development Tumors Cancer Care Basilea Pharmaceutica Patient's Tumor
Is CSBR a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 17.9
52 Week Low 5.2
Average Volume 24,990
200-Day Moving Average 9.2688
50-Day Moving Average 7.4729
20-Day Moving Average 6.3233
10-Day Moving Average 5.8425
Average True Range 0.431
ADX 20.21
+DI 19.7696
-DI 24.6677
Chandelier Exit (Long, 3 ATRs ) 6.807
Chandelier Exit (Short, 3 ATRs ) 6.493
Upper Bollinger Band 7.4577
Lower Bollinger Band 5.1889
Percent B (%b) 0.44
BandWidth 35.879999
MACD Line -0.4962
MACD Signal Line -0.5446
MACD Histogram 0.0484
Fundamentals Value
Market Cap 67.88 Million
Num Shares 11 Million
EPS -0.46
Price-to-Earnings (P/E) Ratio -13.43
Price-to-Sales 2.13
Price-to-Book 125.38
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 6.95
Resistance 3 (R3) 6.87 6.53 6.82
Resistance 2 (R2) 6.53 6.33 6.57 6.78
Resistance 1 (R1) 6.36 6.21 6.44 6.44 6.74
Pivot Point 6.02 6.02 6.06 6.06 6.02
Support 1 (S1) 5.84 5.82 5.93 5.92 5.62
Support 2 (S2) 5.50 5.70 5.54 5.58
Support 3 (S3) 5.33 5.50 5.54
Support 4 (S4) 5.41